Literature DB >> 15778397

Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene.

Toshikatsu Hanada1, Kentaro Tanaka, Yumiko Matsumura, Moriyasu Yamauchi, Hitomi Nishinakamura, Hiroyuki Aburatani, Ryuichi Mashima, Masato Kubo, Takashi Kobayashi, Akihiko Yoshimura.   

Abstract

Suppressor of cytokine signaling (SOCS1/JAB) has been shown to play an important role in regulating dendritic cell (DC) function and suppressing inflammatory diseases and systemic autoimmunity. However, role of SOCS1 in DCs for the initiation of Th cell response has not been clarified. Here we demonstrate that SOCS1-deficient DCs induce stronger Th1-type responses both in vitro and in vivo. SOCS1-deficient DCs induced higher IFN-gamma production from naive T cells than wild-type (WT) DCs in vitro. Lymph node T cells also produced a higher amount of IFN-gamma when SOCS1-deficient bone marrow-derived DCs (BMDCs) were transferred in vivo. Moreover, SOCS1(-/-) BMDCs raised more effective anti-tumor immunity than WT BMDCs. Microarray analysis revealed that IFN-inducible genes were highly expressed in SOCS1-deficient DCs without IFN stimulation, suggesting hyper STAT1 activation in SOCS1(-/-) DCs. These phenotypes of SOCS1-deficient DCs were similar to those of CD8alpha(+) DCs, and in the WT spleen, SOCS1 is expressed at higher levels in the Th2-inducing CD4(+) DC subset, relative to the Th1-inducing CD8alpha(+) DC subset. We propose that reduction of the SOCS1 gene expression in DCs leads to CD8alpha(+) DC-like phenotype which promotes Th1-type hyperresponses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778397     DOI: 10.4049/jimmunol.174.7.4325

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

2.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.

Authors:  Kevin Evel-Kabler; Xiao-Tong Song; Melissa Aldrich; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

Review 3.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 4.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

5.  A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy.

Authors:  Chang-Han Chen; Shau-Hsuan Li
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 6.  SOCS1 and its Potential Clinical Role in Tumor.

Authors:  Jie Ying; Xiaoyan Qiu; Yu Lu; Miaomiao Zhang
Journal:  Pathol Oncol Res       Date:  2019-02-13       Impact factor: 3.201

7.  Novel mechanisms underlying the immediate and transient global tolerization of splenic dendritic cells after vaccination with a self-antigen.

Authors:  Adam M Farkas; Olivera J Finn
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

8.  Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.

Authors:  Nicole Meissner; Steve Swain; Kate McInnerney; Soo Han; Allen G Harmsen
Journal:  Am J Pathol       Date:  2010-04-15       Impact factor: 4.307

Review 9.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

10.  Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells.

Authors:  Bangxing Hong; Wenhong Ren; Xiao-Tong Song; Kevin Evel-Kabler; Si-Yi Chen; Xue F Huang
Journal:  Cancer Res       Date:  2009-09-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.